Phoenix, July 06, 2016 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (PINKSHEETS: ONOV) is pleased to announce the results of its biodegradable fungicide, CR-10, after six months of Coffee Rust testing in Costa Rica.
CoopeAgri R.L, one of the largest cooperative in Costa Rica, has released the CR-10 performance data. The results show that eco-friendly CR-10 has not only brought the coffee rust to a level of 0% in all the tested coffee plantations, but it has maintained this level without any new application for a period of 120 days. Also, all coffee trees treated with CR-10 show that their foliage has doubled, proving that they regain some of their life force, which doesn’t happen when they are treated with toxic chemicals.
Mr. Jean Ekobo, President/CEO of BioNovelus, Inc., says, "This additional performance of CR-10 shows that unlike its toxic competition, CR-10 doesn’t require any additional byproduct (such as sulfur) to stick to plants. CR-10 also quickly kills coffee rust while protecting plants from being (re)infected.”
These results have open doors to a potential distribution partner in Mexico with one of the leading distributors of “green” agricultural solutions, eco-friendly fungicides and bio-pesticides. This Mexican company, excited about the results with the “roya” fungus, has offered its research and development team to test CR-10 not just on coffee rust, but for other agricultural applications such as soy bean, banana, papaya, pineapple, tomatoes and wheat. Positive test results will be a tremendous asset for BioNovelus in the future.
According to the US Department of Agriculture (USDA) “Mexico is by far the most important supplier of fresh produce to the U.S., accounting for 69% of U.S. fresh vegetable import value and 37% of U.S. fresh fruit import value in 2012, (…) and increasing by an average of 20% per year.
About BioNovelus Inc.
BioNovelus, Inc. (PINKSHEETS: ONOV) is a biotech company that honors the environment with an innovative, cost effective and disruptive technology-based solution to the problems of safety and cleanliness regarding food production and water supply.
BioNovelus’ primary target market is the coffee industry, worth over $100B annually worldwide. Coffee Rust or "Roya" (Hemileia vastatrix), is a devastating fungus attacking the Arabica plant, currently, the coffee industry’s greatest threat, so far, costing $2.5 billion dollars and 500,000 jobs in Central America since 2012.
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2015 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.
Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of paper and other raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
SOURCE: BioNovelus Inc.